Jump to ContentJump to Main Navigation
Show Summary Details
More options …

International Journal of Occupational Medicine and Environmental Health

More options …

The medical perspective on burnout

Tamar Kakiashvili
  • Sudbury Therapy, Psychotherapy, Ontario, Canada
  • Sudbury Therapy, Psychotherapy, 885 Regent Street, Sudbury, Ontario, Canada, P3E 5M4
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jerzy Leszek / Krzysztof Rutkowski
Published Online: 2013-09-10 | DOI: https://doi.org/10.2478/s13382-013-0093-3

Abstract

Keywords: Burnout; Stress; Pathophysiology; Cortisol

  • [1] Appels A. Why do imminent victims of a cardiac event feel so tired? Int J Clin Pract 1997;51:447–450. Google Scholar

  • [2] Maslach C, Schaufeli WB, Leiter MP. Job burnout. Annu Rev Psychol 2001;52:397–422. CrossrefGoogle Scholar

  • [3] Hallman T, Thomsson H, Burell G, Lisspers J, Setterlind S. Stress, burnout and coping: differences between women with coronary heart disease and healthy matched women. J Health Psychol 2003;8(4):433–445. CrossrefGoogle Scholar

  • [4] Appels A, Mulder P. Fatigue and heart disease. The association between ‘vital exhaustion’ and past, present and future coronary heart disease. J Psychosom Res 1989;33:727–738. CrossrefGoogle Scholar

  • [5] Pedersen SS, Middel B. Increased vital exhaustion among type-D patients with ischemic heart disease. J Psychosom Res 2001;51(2):443–449. CrossrefGoogle Scholar

  • [6] Räikkönen K, Lassila R, Keltikangas-Järvinen L, Hautanen A. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler Thromb Vasc Biol 1996;16(3):363–367. Google Scholar

  • [7] Keltikangas-Järvinen L, Räikkönen K, Hautanen A, Adlercreutz H. Vital exhaustion, anger expression, and pituitary and adrenocortical hormones. Implications for the insulin resistance syndrome. Arterioscler Thromb Vasc Biol 1996;16(2):275–280. CrossrefGoogle Scholar

  • [8] Nicolson NA, van Diest R. Salivary cortisol patterns in vital exhaustion. J Psychosom Res 2000;49(5):335–342. CrossrefGoogle Scholar

  • [9] Sandstrom A, Rhodin IN, Lundberg M, Olsson T, Nyberg L. Impaired cognitive performance in patients with chronic burnout syndrome. Biol Psychol 2005;69:271–279. CrossrefGoogle Scholar

  • [10] Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol 1994;13:291–298. CrossrefGoogle Scholar

  • [11] Maslach C, Jackson SE, Leiter MP. Maslach Burnout Inventory. Palo Alto, CA: Consulting Psychologist Press; 1996. Google Scholar

  • [12] Barbosa FT, Leao BA, Tavares GM, Santos JG. Burnout syndrome and weekly workload of on-call physicians: Cross-sectional study. Sao Paulo Med J 2012;130(5):282–288. CrossrefGoogle Scholar

  • [13] Farber BA. Burnout in psychotherapists: Incidence, types, and trends. Psychother Priv Pract 1990;8(1):35–44. _07Google Scholar

  • [14] Farber BA. Treatment strategies for different types of teacher burnout. J Clin Psychol 2000;56:675–689. :5<675::AID-JCLP8>3.0.CO;2-DGoogle Scholar

  • [15] Montero-Marín J, García-Campayo J, Mosquera Mera D, López del Hoyo Y. A new definition of burnout syndrome based on Farber’s proposal. J Occup Med Toxicol 2009;4(31):1–17. Google Scholar

  • [16] Montero-Marín J, García-Campayo J, Fajó-Pascual M, Carrasco JM, Gascón S, Gili M, et al. Sociodemographic and occupational risk factors associated with the development of different burnout types: The cross-sectional University of Zaragoza study. BMC Psychiatry 2011;11(49):1–13. Google Scholar

  • [17] Trickett S. Withdrawal from benzodiazepines. J R Coll Gen Pract 1983;33:608. Google Scholar

  • [18] Lader M, Morton S. Benzodiazepine problems. Br J Addict 1991;86:823–828. CrossrefGoogle Scholar

  • [19] Michelini S, Cassano GB, Frare F, Perugi G. Long-term use of benzodiazepines: Tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry 1996;29:127–134. CrossrefGoogle Scholar

  • [20] Opstad K. Circadian rhythm of hormones is extinguished during prolonged physical stress, sleep and energy deficiency in young men. Eur J Endocrinol 1994;131:56–66. CrossrefGoogle Scholar

  • [21] Ekstedt M, Söderström M, Akerstedt T, Nilsson J, Søndergaard HP, Aleksander P. Disturbed sleep and fatigue in occupational burnout. Scand J Work Environ Health 2006;32(2):121–131. CrossrefGoogle Scholar

  • [22] Doghramji K. Approach to the patient with a sleep or wakefulness disorder. The Merck Manual Online. [cited 2013 June 20]. Available from http://www.merckmanuals.com/professional/neurologic_disorders/sleep_and_wakefulness_disorders/approach_to_the_patient_with_a_sleep_or_wakefulness_disorder.html Google Scholar

  • [23] Ahola K, Honkonen T, Virtanen M, Kivimäki M, Isometsä E, Aromaa A, et al. Interventions in relation to occupational burnout: The population-based health 2000 study. J Occup Environ Med 2007;49(9):943–952. CrossrefGoogle Scholar

  • [24] Juster RP, Sindi S, Marin MF, Perna A, Hashemi A, Pruessner JC, et al. A clinical allostatic load index is associated with burnout symptoms and hypocortisolemic profiles in healthy workers. Psychoneuroendocrinology 2011;36(6):797–805. CrossrefGoogle Scholar

  • [25] Sonnenschein M, Mommersteeg PM, Houtveen JH, Sorbi MJ, Schaufeli WB, van Doornen LJ. Exhaustion and endocrine functioning in clinical burnout: An in-depth study using the experience sampling method. Biol Psychol 2007;75(2):176–184. CrossrefGoogle Scholar

  • [26] Pariante CM, Hye A, Williamson R, Makoff A, Lovestone S, Kerwin RW. The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology 2003;28:1553–1561. DOI: 10.1038/sj.npp.1300195. CrossrefGoogle Scholar

  • [27] Pariante CM, Kim RB, Makoff A, Kerwin RW. Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters. Br J Pharmacol 2003;139:1111–1118. CrossrefGoogle Scholar

  • [28] Karssen AM, Meijer OC, van der Sandt I, Lucassen PJ, de Lange EC, de Boer AG, et al. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 2001;142(2):686–694. CrossrefGoogle Scholar

  • [29] Hotze SF. Adrenal Fatigue & Cortisol [cited 2013 June 20]. Available from http://www.cushings-help.com/downloads/adrenal.pdf Google Scholar

  • [30] Schuder SE. Stress-Induced Hypocortisolemia Diagnosed as Psychiatric Disorders Responsive to Hydrocortisone Replacement. Ann N Y Acad Sci 2005;1057:466–478. CrossrefGoogle Scholar

  • [31] Sagud M, Pivac N, Mück-Seler D, Jakovljević M, Mihaljević-Peles A, Korsić M. Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients. Neuropsychobiology 2002;45:139–143. CrossrefGoogle Scholar

  • [32] Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, et al. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: Implications for the treatment of alcoholism. Alcohol Clin Exp Res 1998;22(7):1430–1436. CrossrefGoogle Scholar

  • [33] Petrosino S, Di Marzo V. FAAH and MAGL inhibitors: Therapeutic opportunities from regulating endocannabinoid levels. Curr Opin Invest Drugs 2010;11(1):51–62. Google Scholar

  • [34] Guilliams TG, Edwards L. Chronic stress and the HPA axis: Clinical assessment and therapeutic considerations. The review of natural & neutraceutical therapies for clinical practice. Standard 2010;9(2):1–12. Google Scholar

  • [35] Hamazaki K, Itomura M, Huan M. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: A randomized, placebo-controlled, double-blind trial. Nutrition 2005;21:705–710. CrossrefGoogle Scholar

  • [36] Delarue J, Matzinger O, Binnert C. Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab 2003;29:289–295. CrossrefGoogle Scholar

  • [37] Hamazaki T, Itomura M, Sawazaki S, Nagao Y. Antistress effects of DHA. Biofactors 2000;13:41–45. CrossrefGoogle Scholar

  • [38] Krähenbühl S, Hasler F, Frey BM, Frey FJ, Brenneisen R, Krapf R. Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans. J Clin Endocrinol Metab 1994;78(3):581–585. Google Scholar

  • [39] Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 2006;46(3):167–192. CrossrefGoogle Scholar

  • [40] Head KH, Kelly GS. Nutrients and botanicals for treatment of stress: Adrenal fatigue, neurotransmitter imbalance, anxiety, and restless sleep. Altern Med Rev 2009;14(2):114–140. Google Scholar

  • [41] Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol 2009;4(3):198–219. CrossrefGoogle Scholar

  • [42] Pruessner JC, Hellhammer DH, Kirschbaum C. Burnout, perceived stress, and cortisol responses to awakening. Psychosom Med 1999;61(2):197–204. CrossrefGoogle Scholar

  • [43] Clarke DM, Kissane DW. Demoralization: Its phenomenology and importance. Aust N Z J Psychiatry 2002;36(6):733–742. CrossrefGoogle Scholar

  • [44] Gabel S. Demoralization in mental health organizations: Leadership and social support help. Psychiatr Q 2012;83(4):489–496. CrossrefGoogle Scholar

  • [45] West CP, Dyrbye LN, Satele DV, Sloan JA, Shanafelt TD. Concurrent validity of single-item measures of emotional exhaustion and depersonalization in burnout assessment. Gen Intern Med 2012;27(11):1445–1452. CrossrefGoogle Scholar

  • [46] Greaves-Lord K, Ferdinand RF, Oldehinkel AJ, Sondeijker FE, Ormel J, Verhulst FC. Higher cortisol awakening response in young adolescents with persistent anxiety problems. Acta Psychiatr Scand 2007;116(2):137–144. CrossrefGoogle Scholar

  • [47] Kanter ED, Wilkinson CW, Radant AD, Petrie EC, Dobie DJ, McFall ME, et al. Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder. Biol Psychiatry 2001;50(4):238–245. CrossrefGoogle Scholar

  • [48] Moch SL, Panz VR, Joffe BI, Havlik I, Moch JD. Longitudinal changes in pituitaryadrenal hormones in South African women with burnout. Endocrine 2003;21(3):267–272. :21:3:267CrossrefGoogle Scholar

  • [49] Kellner M, Yehuda R, Arlt J, Wiedemann K. Longitudinal course of salivary cortisol in post-traumatic stress disorder. Acta Psychiatr Scand 2002;105(2):153–155 CrossrefGoogle Scholar

  • [50] Yehuda R, Brand SR, Golier JA, Yang RK. Clinical correlates of DHEA associated with post-traumatic stress disorder. Acta Psychiatr Scand 2006;114(3):187–193. CrossrefGoogle Scholar

  • [51] Tiller JW, Biddle N, Maguire KP, Davies BM. The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder. Biol Psychiatry 1988;23(3):261–270. CrossrefGoogle Scholar

  • [52] Montero-Marín J. The ‘Burnout Clinical Subtype Questionnaire’ (BCSQ-36/BCSQ-12): A new definition of burnout through a differential characterization of the syndrome. Huesca: Ediciones GH; 2012. p. 106. Google Scholar

About the article

Published Online: 2013-09-10

Published in Print: 2013-06-01


Citation Information: International Journal of Occupational Medicine and Environmental Health, Volume 26, Issue 3, Pages 401–412, ISSN (Online) 1896-494X, DOI: https://doi.org/10.2478/s13382-013-0093-3.

Export Citation

© 2013 Nofer Institute of Occupational Medicine Łódź, Poland.

Comments (0)

Please log in or register to comment.
Log in